HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A clinical evaluation of sultamicillin fine granules in the treatment of meibomianitis].

Abstract
This study was performed to evaluate the clinical efficacy and the safety of sultamicillin (SBTPC) fine granules in the treatment of patients with meibomianitis. A dose of 375 mg SBTPC granules was orally given to 10 patients with meibomianitis after each meal, three times a day. The results obtained are summarized as follows. Efficacies were rated as good in 7 cases, fair in 2 and poor in 1 with an efficacy ratio of 70.0%. No side effects were observed throughout the study. The organisms isolated were Gram-positive bacteria such as Staphylococcus aureus, Staphylococcus epidermidis, coagulase negative Staphylococcus and Streptococcus sanguis, and Gram-negative bacteria such as Alcaligenes denitrificans subsp. denitrificans, Alcaligenes denitrificans subsp. xylosoxidans, Xanthomonas maltophilia and Acinetobacter lwoffii. A bacteriological study showed lower MICs of SBTPC than those of ampicillin (ABPC), suggesting that SBTPC has more potent antibacterial activity than ABPC. Such bacteriological activity of SBTPC was well reflected in its clinical efficacy; the drug was effective in patients with infections caused by organisms moderately or highly resistant to ABPC or cefaclor.
AuthorsM Ooishi, M Miyao
JournalThe Japanese journal of antibiotics (Jpn J Antibiot) Vol. 41 Issue 12 Pg. 2059-64 (Dec 1988) ISSN: 0368-2781 [Print] Japan
PMID3249376 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Dosage Forms
  • sultamicillin
  • Ampicillin
  • Sulbactam
Topics
  • Administration, Oral
  • Adult
  • Aged
  • Ampicillin (administration & dosage, pharmacology, therapeutic use)
  • Ampicillin Resistance
  • Bacteria (drug effects)
  • Bacterial Infections (drug therapy, microbiology)
  • Dosage Forms
  • Drug Evaluation
  • Drug Therapy, Combination (administration & dosage, pharmacology, therapeutic use)
  • Eyelid Diseases (drug therapy, microbiology)
  • Female
  • Humans
  • Meibomian Glands
  • Middle Aged
  • Sulbactam (administration & dosage, pharmacology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: